Announced Fri, 23 Oct, 2026 · 12:07 IST

Board to approve September quarter unaudited results

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹60.00

prior close

₹59.92

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.3%+2.3% vs market

Pharmaceuticals peers, median of 170sector-1.6%+1.6% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.7

10m

+2.7

15m

+2.7

30m

+2.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0-2.3+2.3-1.6+1.6

Next day

+1.7-1.9+3.6-0.5+2.1

+1.5-0.2+1.7+1.5-0.0

+2.3pendingpending+2.5-0.2

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board will meet on 4 November 2026 to approve the company's unaudited financial results for the quarter ended 30 September 2026. Trading remains closed for designated persons until 48 hours after the results are declared. No financial figures or auditor changes are disclosed.

Likely market impact

This is a routine results meeting notice. The stock may react when the results are published; this filing provides no performance data.